Oncothermia Journal Volume 6

“Abstract Pancreas cancer (PCA) is an aggressive, common malignant tumor. We present two retrospective clinical studies of PCA done in two medical centers (HTT-MED Day-clinic and Peterfy Hospital). Both of the centers made the treatments by oncothermia in combination with the conventional tumor-therapies. We present the data from both centers and make a metaanalysis of the data as well. Results show a remarkable survival benefit for the patients compared to the historical data.

“Introduction The demand for integrative oncology is on the upswing as both patients and doctors grow impatient with the failed war on cancer, internationally. More and more physicians move away from a one-size-fits-all kind of treatment to an integrated, patient-centered approach as we practice it at St. George Hospital, since more than twenty years. Cancer is a multibillion Euro market that is growing fast and companies make a lot of money on something that doesn't work that well. Metastases are the major cause of death in cancer.

“We focus upon treating patients individually, and addressing the particular characteristics of their cancers, as well as their ability to detoxify. This includes stimulating the immune system to help it recognize cancer. We use three non toxic treatment modalities to destruct cancer within the body, so that it can be recognized by the immune system. This is in the first line hyperthermia (heat treatment), electro cancer therapy (ECT) and photodynamic therapy (PDT).

“Introduction Early detection of prostate cancer (PC), as, in all malignancies, is very important, so that withappropriate therapy the chances of a cure increase. The prostate cancer screening guidelines suggest, next to surgical removal of the prostate (prostatectomy) and the various forms of radiation, to monitor the patient through “Active Surveillance”. This controlled and regularly executed observation is especially used in patients with a slow-growing tumor (so-called insignificant prostate cancer).

"Hyperthermic procedures are now classified as medically necessary medical treatment for various tumor identities in civil justice, whose costs are to be reimbursed by the private health insurance companies. Despite the explicit assessment of hyperthermia as a treatment method which has not been acknowledged in the treaty care sector, the statutory health insurance schemes are also increasingly being condemned in life-threatening situations in order to grant hyperthermic treatments in kind. "